Build or improve a coherent health and wellness system.

Basilia Health helps organisations improve an existing employee health and wellness system, or design a coherent one where none yet exists — mapping what is there, deciding what should change, and building the strategy, measurement and governance to make it work.

This is physician-led, evidence-led work. Individual clinical information stays within the clinician–patient relationship; the organisation receives agreed operational information and carefully controlled aggregate reporting only.

Physician-led · Privacy-bounded

Do you already have a health and wellness system, or are you building one?

Almost all organisational health work begins here. If you already have some combination of a wellness programme, providers, benefits, facilities, employee-health services, health spend, programme governance or partly developed system architecture, the question is what exists, whether it is any good, and what should change. If you have only disconnected activities — or are starting from near zero — the question is what to build, for whom, and how you will know it is useful.

Your answer decides the entry pathway. Everything else Basilia offers organisations follows from what that first piece of work finds — it is not a menu to choose from up front.

Answer the right question first, and the rest of the work follows.

Two primary pathways, depending on where you are.

Both pathways are physician-led and evidence-led, and both build toward a coherent system you can measure and govern. Which one fits depends only on whether a system already exists.

When organisational enquiries open, engagement will begin with a discovery conversation to confirm fit, scope and readiness. What each pathway involves is described so intended scope is clear before that conversation.

If you already have a system

Health & Wellness Programme Audit & Strategy

You have some combination of a wellness programme, providers, benefits, facilities, employee-health services, health spend, programme governance or partly developed system architecture.

What already exists, is it any good, and what should change?

What Basilia does

  • Maps the current system.
  • Assesses evidence, fit, access, utilisation, duplication and gaps.
  • Evaluates whether relevant organisational conditions enable or undermine effectiveness.
  • Distinguishes programme-level issues from deeper work-system issues.
  • Defines what to retain, modify, stop, add or investigate further.
  • Redesigns the target-state health and wellness system.
  • Creates the measurement and governance framework and an implementation roadmap.

The decision it enables

A clear, evidence-based plan for what to keep, change, stop and build — and how you will know it worked.

If you are building or resetting a system

Health & Wellness System Strategy & Design

You do not yet have a coherent employee health and wellness system — only disconnected activities or benefits — or you want to reset the system fundamentally rather than audit an established one.

What should we build, for whom, why, how should it work, and how will we know it is useful?

What Basilia does

  • Defines workforce and system needs.
  • Clarifies strategic purpose and intended outcomes.
  • Identifies justified priority populations.
  • Designs the target-state system architecture.
  • Defines pathways, providers, access and funding logic.
  • Establishes clinical and organisational interfaces.
  • Creates baseline, measurement and governance architecture.
  • Defines a minimum viable system and a phased implementation roadmap.

The decision it enables

A defensible design for a coherent system — who it serves, how it works, what it takes to run, and how its usefulness will be judged.

Both pathways are part of Basilia's Health & Wellness System Strategy work. Neither is a menu of wellness activities; both are designed to produce a system you can run, measure and govern.

Both routes build toward the same thing.

Whether Basilia audits an existing system or designs a new one, the work converges on a system an organisation can actually run and improve.

Both pathways produce:

  • A coherent target-state health and wellness system.
  • Clear provider roles and pathways.
  • A measurement framework.
  • A governance model.
  • A phased implementation roadmap.

The system is designed workforce-wide first; differentiated pathways for priority populations — executives, MANCO, critical or safety-sensitive roles — are added only where the evidence and the organisation's needs justify them. Not every organisation needs an executive pathway.

Measurement is part of the work, not an afterthought.

Measurement is designed in from the start: define the intended outcome, establish appropriate baseline information where possible, distinguish process measures from outcome measures, and re-measure to see what actually changed. Programme-level measurement is reported in aggregate under privacy safeguards.

It cannot establish that a change caused a business outcome. Selection, baseline differences, missing data and small groups all limit interpretation. Basilia does not promise reduced absenteeism, increased productivity, improved profit or a return on investment, and states the causal limits of any measure honestly.

Where external evidence is discussed, its population and measurement limits are stated and it is not presented as a Basilia result.

Basilia's organisational measurement methods, including the Basilia Organisational Capacity Index, are still being developed. Basilia does not present the Capacity Index as validated, and does not claim validated thresholds, benchmarks, predictive validity or certification. No composite measure is presented as validated or predictive.

What may follow — only if the work calls for it.

Everything below is downstream of the two pathways above. Each is conditional on what the Audit or the Strategy & Design finds — none is automatically delivered, and none is a starting offer.

Implementation support

In development

Where the strategy identifies changes Basilia should help implement.

Health & Wellness Programme Governance

In development

Where the client needs ongoing programme stewardship — provider review, KPI review and an annual strategy refresh. It is not administrative PMO work or generic HR governance.

Executive Health Intelligence Retainer

In development

Where leadership needs bounded, ongoing evidence and advisory support. It does not provide individual clinical care through an employer retainer.

Differentiated executive, senior-manager or priority-population pathways

In development

Where genuinely justified by need — never automatically included.

Partner-enabled clinical layer

In development

Where individual clinical care is required. Patient-level care is delivered through the appropriately licensed treating clinician (see the boundaries below); Basilia does not currently operate its own clinical service.

Organisational Capacity Review

In development

An escalation, not part of the Audit or Strategy & Design. Where deeper work-system constraints appear — chronic overload, meeting architecture, decision burden, systemic recovery constraints, travel design or broader operating conditions — Basilia may recommend a separate Organisational Capacity Review that diagnoses the work system.

Organisational Capacity Partnership

In development

Where a longer-term measure → change → re-measure relationship is justified.

In development
scope and delivery model are still being developed.

The Programme Audit & Strategy and System Strategy & Design pathways address the health and wellness system — services, providers, pathways, access, evidence, measurement and governance, and only the organisational conditions that materially affect it. The Organisational Capacity Review addresses the work system — workload, meetings, travel, after-hours expectations, interruptions, decision burden and systemic recovery. Basilia keeps them distinct and does not fold one into the other.

None of these is generally available yet. Basilia Health is based in Namibia, and organisational engagements are being developed within confirmed clinical and operational capacity. Any future pricing would be determined by scope — participants, depth, delivery and reporting — rather than a published fixed price.

Clinical executive health is one pathway, not the whole offer.

Where an organisation sponsors individual clinical assessment for leaders or other critical roles, that is one differentiated pathway inside the broader system — not the whole organisational offer. Where individual clinical care is required, it is delivered through the appropriately licensed clinical provider responsible for that patient's care. Basilia's near-term clinical model is partner-enabled: Basilia leads the programme, and direct Basilia clinical delivery remains a future capability subject to the required infrastructure and governance.

Basilia currently leads, at programme level

  • Programme architecture and design.
  • Evidence standards.
  • Provider and pathway architecture.
  • The participant experience and coordination.
  • Measurement architecture.
  • Programme-level reporting and governance.

A licensed treating clinical provider is responsible for, at patient level

  • Medical history and physical examination.
  • Patient-level clinical interpretation and diagnosis.
  • Treatment, prescribing and regulated diagnostic work.
  • Clinical documentation and responsibility for the patient's clinical care.

Basilia may develop more of this clinical delivery directly over time. That is a future direction; Basilia does not currently operate its own full executive-health clinical service.

This clinical pathway is in development and is not generally available. The privacy and confidentiality boundaries below apply to it in full.

The employer may fund the service. The individual remains the patient.

Individual clinical information is handled within the clinician–patient relationship, subject to informed consent, professional duties and applicable law. Employers receive only agreed operational information and carefully controlled de-identified aggregate reporting where the required consent, minimum-cohort and disclosure safeguards are met.

Participation in individual clinical assessment and care is voluntary. Declining must not be treated as misconduct, and the organisation does not receive individual clinical results.

The organisation purchases a programme, not access to a medical record.

  • Programme implementation status — may be shared within the agreed scope.
  • Enrolment or completion counts — may be shared where contracted, without exposing individual reasons.
  • Aggregate outcomes — may be shared only when privacy and disclosure safeguards are met.
  • Organisational recommendations — may be shared without identifying participants.
  • Individual clinical reports — not shared by default.
  • Diagnoses, medications, laboratory results and individual health profiles — not shared by default.
View the detailed employer-information boundaries
What an employer may and may not receive (Privacy, Consent and Employer Reporting Framework §11)
CategoryStandard reporting positionConditions
Contract and implementation statusYesScope, milestones, invoices, programme-level issues
Invitation / enrolment countsYes, if contractedCounts only; avoid exposing reasons for non-participation
Named scheduling statusOnly if necessaryDisclose in advance; restrict to authorised gatekeepers; no clinical status
Named completion statusOnly if necessary and disclosed“Completed” must not imply fitness, diagnosis or outcome
Individual clinical reportNoSpecific express consent or narrow legal/serious-harm basis
Diagnosis, medication, laboratory resultNoDo not disclose by default
Individual health score or profileNoDo not disclose by default; a code is not sufficient protection
Aggregate outcomesYes, when safeMinimum cohort, cell suppression, de-identification and disclosure review
Programme recommendationsYesMust not expose individuals; distinguish clinical findings from organisational observations
Urgent safety matterExceptionallyClinical lead decision; minimum necessary; legal/professional advice where feasible
Fitness / work capacity conclusionOnly under a separate occupational pathwaySpecific purpose, consent, scope and reporting standard

Two models, deliberately distinct.

A clinical engagement is not a fixed programme. The participant journey describes what an individual may experience. The Basilia method describes how information is assessed and acted on clinically. They are related but distinct, and the exact scope would be agreed for each engagement.

Participant journey

  1. Invitation
  2. Consent
  3. Assessment
  4. Plan
  5. Implementation
  6. Reassessment

Basilia method

  1. MeasureEstablish what is present and relevant.
  2. InterpretRead findings in clinical context.
  3. PrioritiseDecide what matters most now.
  4. ImplementAct on what was prioritised.
  5. TrackFollow what was implemented.
  6. ReassessRe-examine and adjust.

Where a finding requires further medical assessment or specialist input, it is communicated and escalated through the participant's clinical care—not reported to the organisation unless the participant specifically authorises disclosure or a narrow legal or serious-harm basis applies.

Clinical governance and privacy

Clinical findings and organisational observations remain distinct.

Clinical care is accountable to the treating clinician's clinical-governance structure rather than to the sponsoring organisation.

More information is not always better.

Tests should answer a defined clinical question, have an interpretation pathway and be capable of changing management. Basilia's model favours relevant assessment and diagnostic governance over indiscriminate screening.

Basilia does not rank individuals by health risk, name individuals behind aggregate trends, disclose who declined or screened positive, share raw records, or support the use of clinical data for selection, discipline, remuneration or performance management.

Start with a discovery conversation.

You do not need to choose a product name up front. A first, non-clinical conversation establishes whether you are improving an existing system or building a new one — and therefore whether Health & Wellness Programme Audit & Strategy or Health & Wellness System Strategy & Design is the right entry pathway — along with what reporting would and would not include and whether the privacy boundaries work for everyone.

Organisational enquiries will open in a later phase.

When enquiries open, please do not send clinical or personal health information through the website.